Core Laboratories NV (CLB)
Financial leverage ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | ||
|---|---|---|---|---|---|
| Total assets | US$ in thousands | 590,406 | 600,466 | 597,799 | 587,950 |
| Total stockholders’ equity | US$ in thousands | 251,991 | 250,742 | 240,274 | 232,155 |
| Financial leverage ratio | 2.34 | 2.39 | 2.49 | 2.53 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $590,406K ÷ $251,991K
= 2.34
The financial leverage ratio for Core Laboratories NV has shown a decreasing trend over the four quarters of 2024, declining from 2.53 in March to 2.34 in December. This indicates that the company is relying less on debt financing and more on equity to fund its operations and investments during the year. A decreasing financial leverage ratio can be seen as a positive sign as it signifies a lower level of financial risk and potential instability due to excessive debt. Overall, Core Laboratories NV's decreasing financial leverage ratio suggests a strong and sustainable financial position.
Peer comparison
Dec 31, 2024